A study to compare the efficacy of cyclophosphamide versus multi-drug therapy in the treatment of lupus nephritis
Not Applicable
- Conditions
- Health Condition 1: null- Lupus Nephritis
- Registration Number
- CTRI/2017/05/008697
- Lead Sponsor
- Director
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 88
Inclusion Criteria
1. SLE diagnosis by ACR criteria
2. Lupus nephritis class III, IV, V, a combination of III+V or IV+V
3. Serum creatinine <3.0mg/dl
Exclusion Criteria
1. Severe proliferative lupus nephritis on Histopathologic Examination (eg. Crescents in >50% of the glomeruli)
2. Ongoing infection
3. Pregnant females
4. Low TLC count
5. Previously received immunosuppressive treatment
6. Patient not giving consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method